The 2nd Next Generation RNA Therapeutics Summit returns as the first and only industry-dedicated forum solely focused on next generation RNA therapeutics and vaccines that are more targeted, and efficacious, with reduced off targets than first generation RNA therapies to accelerate their therapeutic and commercial potential.

Expect exclusive data from KOLs on the most recent developments in circRNAs, saRNAs, eRNAs and tRNAs therapies.

Join 100+ thought leaders from the likes of Pfizer, Orna Therapeutics, Laronde, Replicate Bioscience and BioNTech to stay ahead of the curve and maximize the full therapeutic potential of next generation RNA modalities to gain clinical proof concept and reach patients in need.

Read on rna.com

Following the approval of Amylyx's Relyvrio in the US and Canada and further FDA decisions on the horizon in 2023, the ALS drug development landscape is gaining momentum and positivity. With booming pharma investment and new biotechs entering the field, there are still crucial translational challenges to address to bridge the gap and see clinical success for the wider ALS patient population.

Returning to Boston, the timely 2nd Annual ALS Drug Development Summit is the only industry-focused conference dedicated to overcoming preclinical and clinical challenges currently facing ALS pipelines. This is your must-attend meeting showcasing the latest breakthroughs in ALS in 2022 and 2023.

Read on go.evvnt.com

Following the success of the 2nd Annual Psychedelic Therapeutics and Drug Development Conference in 2022, we're thrilled to be hosting the 3rd Annual event on May 15-16, 2023 in Washington, DC. This event has been organized to bring together the world's leading researchers and leaders in academia, industry, the non-profit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.

Our speakers and panelists will be covering important topics such as Clinical Trial Design, Intellectual Property, Regulatory Guidance, Psychedelic Drug Delivery, Commercialization, Legal Issues, Emerging Preclinical Science, and New Clinical Data among other topics. This event has been designed and curated for the benefit of key stakeholders in this burgeoning area and will provide practical guidance, discussion and networking.

Read on go.evvnt.com

PEGS Boston Summit is recognized as the leading international meeting place for the biotherapeutics community. covering a wide spectrum of biologic drug development.

Experience the Future of Biotherapeutic Drug Development Welcome to PEGS Boston The world’s largest gathering of protein engineering and biotherapeutics experts is back in Boston! PEGS Boston Summit is the leading biologics event with comprehensive programming covering all aspects of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytics, immunogenicity, and more. Harness the power of in-person events, form genuine connections, create valuable relationships with peers, and become part of the PEGS community.

Read on cii.dryfta.com

Greetings! Scientex Conference the Otolaryngology Event is to be Scheduled on May 15-16,2023 at Tokyo, Japan. Where you can get a great acumen of the rearmost developments. We play a necessary part in expanding the reach of exploration data in the real- time, which in turn helps in incubating.

Exploration on ENT as a platform for Experimenters, University deans, Professors of vibrant clutter and  University professors, Scholars, Delegates, Health experts, and other experts from the exploration lab, where knowledge transfer takes place through Keynote benefaction, Oral benefaction (live Interaction Sessions), Workshops, councils and Exhibitions.

Read on scientexconference.com

AI-based image analysis is transforming understanding of therapeutic efficacy, disease progression, and patient enrolment. Historically reserved for diagnostic analysis of oncology, evolving applications of digital pathology in NASH, IBS, IBD, CKD, Crohn's Disease, CVD and more has catalysed new approaches to de-risking clinical development through more standardized and cost-effective tissue analysis.

With a sharp focus on leveraging digital pathology and ML beyond oncology, the
Digital Pathology and AI in GI and Fibrotic Diseases Summit is committed to bringing together industry leaders to enhance imaging technologies and algorithm development, evaluate histology as a primary endpoint in trials, and help clarify disease pathology to execute precision medicine.

Read on digital-pathology-fibrotic-diseases.com

M-Health conjointly referred to as mobile health - refers to the apply of drugs and public health supported by mobile devices like mobile phones, tablets, personal digital assistants and therefore the wireless infrastructure at intervals digital health, m-health encompasses all applications of telecommunications and transmission technologies for the delivery of care and health info. Patients receive phone calls or text/voice messages associated with health education, treatment adherence, contacting employees’ doctors, physicians, medical experts or organizing transport to health healthcare workers are provided with needed resources to access the most up-to-date clinical guidelines, collaborate with colleagues, analyse data, receive diagnostic support, and interact with clients.

Read on ehealth.healthconferences.org

The DNA of this congress lies on three axes: Academic, Experience-Sharing, and Innovation.

The scientific committee has prepared an exciting and thought-provoking program, and lectures and presentations of the most updated research and workshops are part of the agenda.

Read on evvnt.com

Join for the premier event of the year for statistical programmers, statisticians, data managers, researchers, and others who analyze data in the life sciences - PharmaSUG 2023! The conference theme, "Putting Digitalization to Work", will be illustrated through 2.5 days of paper presentations, Hands-On Workshops, and opportunities to discuss industry issues with other practitioners from around the world. We are returning to the Hilton San Francisco Union Square, which is just 2 blocks from Union Square and a block from the cable car line, and features panoramic views of the city from San Francisco's highest skybar.

Read on pharmasug.org

The AFIDOC meeting will be associated with The Franco-Israeli Sleep Meeting. The scientific program will include many topics in the field of our specialty presented by prestigious French and Israeli speakers. Save the date and come with us to Jerusalem.

Read on evvnt.com